“Clinical Response and Safety of Alternating Daily Dosage of Crizotinib Due to Side Effects in Advanced NSCLC Patient Harboring ROS1-Rearrangement: A Case Report”. Jurnal Respirologi Indonesia, vol. 43, no. 2, Apr. 2023, pp. 111-5, https://doi.org/10.36497/jri.v43i2.201.